Rhabdomyolysis nursing: assessment, interventions, and NCLEX review

LS
By Lindsay Smith, AGPCNP
Updated April 29, 2026

Rhabdomyolysis is the rapid breakdown of skeletal muscle that releases intracellular contents — myoglobin, creatine kinase (CK), potassium, phosphate, and uric acid — directly into the bloodstream. The result is a cascade of systemic toxicity that can escalate within hours to acute kidney injury (AKI), fatal arrhythmia from hyperkalemia, or disseminated intravascular coagulation (DIC). Hospital incidence is estimated at 26,000 cases per year in the United States, with AKI developing in up to 40% of those cases.

The nursing priorities are straightforward but time-sensitive: identify it early, flood the kidneys with isotonic fluid, and surveil for the electrolyte complications that kill fastest.


Quick reference

DomainKey facts
Classic triadMuscle pain/weakness, dark tea/cola-colored urine, CK >5× upper limit of normal — all three present in <10% of cases
Primary diagnostic markerCK (creatine kinase) — often 10,000–100,000 U/L or higher in severe cases
Most dangerous electrolyte complicationHyperkalemia — causes peaked T waves, wide QRS, sine wave, ventricular fibrillation
Primary treatmentAggressive IV fluid resuscitation with isotonic saline; goal urine output 200–300 mL/hr
IV fluid of choiceNormal saline (NS) — avoid lactated Ringer's (LR) in hyperkalemia (LR contains K+)
Contraindicated medicationNSAIDs — nephrotoxic, worsen AKI risk
Hypocalcemia managementDo NOT aggressively correct early hypocalcemia — bound to damaged muscle; aggressive repletion causes rebound hypercalcemia
Compartment syndrome ruleNever elevate the affected limb above heart level — reduces perfusion to already ischemic muscle
AKI riskMyoglobin precipitates in renal tubules → acute tubular necrosis → [AKI](/nursing-tips/aki-nursing/)

Pathophysiology

Rhabdomyolysis begins with disruption of the skeletal muscle cell membrane — by trauma, ischemia, toxic exposure, or metabolic failure. The membrane disruption triggers two parallel injury pathways.

Calcium influx and energy depletion: Normal muscle cells actively pump calcium out of the cytoplasm using ATP-dependent transporters. When the membrane is disrupted, calcium floods in uncontrolled. The excess intracellular calcium activates proteases and phospholipases that destroy structural proteins, and it drives sustained muscle contraction that rapidly depletes ATP stores. Without ATP, the sodium-potassium pump fails, and the cell swells with water and sodium. The cell then dies.

Intracellular contents spill into the bloodstream: Dead muscle cells release myoglobin, CK, potassium, phosphate, uric acid, and thromboplastin directly into the circulation. Each contributes differently to systemic injury:

  • Myoglobin reaches the renal tubules and precipitates in acidic urine, causing direct tubular obstruction and toxicity. It is broken down into ferrihemate, which is directly nephrotoxic. The result is acute tubular necrosis (ATN) and AKI. Urine volume of 200–300 mL/hr is required to flush myoglobin before it precipitates.
  • Potassium floods out of cells faster than the kidneys can clear it, producing hyperkalemia that can be severe enough to cause lethal arrhythmias.
  • Phosphate rises as cells lyse. Elevated phosphate binds serum calcium, driving early hypocalcemia. Later, as necrotic muscle tissue breaks down further, the deposited calcium is released back into circulation, causing rebound hypercalcemia.
  • Thromboplastin released from necrotic muscle activates the coagulation cascade and can trigger DIC in severe cases.
  • Third-spacing: Damaged muscle takes up large volumes of fluid from the vascular compartment, causing a drop in hemoglobin and effective hypovolemia — which worsens renal perfusion and accelerates AKI.

Three main injury pathways feed into this cascade: direct physical trauma to muscle fibers, energy depletion via ischemia or extreme exertion that starves cells of ATP before membrane failure, and toxic or metabolic injury that directly disrupts membrane integrity or mitochondrial function.


Causes

CategorySpecific causesNotes
TraumaticCrush injury, [compartment syndrome](/nursing-tips/fractures-nursing/), prolonged immobilization, high-voltage electrical injury, circumferential burnsElectrical injury: external burn often underestimates muscle damage — always check CK regardless of wound appearance
Exertional (non-traumatic)Extreme exercise ("exertional rhabdo"), heatstroke, prolonged seizures, delirium tremensHeatstroke temp >40°C (104°F) with CNS dysfunction — cool the patient first, then address rhabdo
Pharmacologic/toxicStatins (especially with CYP3A4 inhibitors), cocaine, heroin, alcohol, PCP, antipsychotics (NMS)Statin risk multiplied dramatically by CYP3A4 inhibitors: grapefruit juice, azole antifungals, macrolides, amiodarone, calcium channel blockers
Infectious/inflammatoryViral myositis (influenza, EBV, COVID-19), necrotizing fasciitis, gas gangrene, [sepsis](/nursing-tips/sepsis-nursing/)Gas gangrene and necrotizing fasciitis: rapidly fatal — emergent surgical debridement required
MetabolicHypokalemia, hypophosphatemia, hypothyroidism, diabetic ketoacidosisHypokalemia and hypophosphatemia both impair muscle energy metabolism directly; correct underlying deficit
Genetic (rare)McArdle disease (glycogen storage type V), carnitine palmitoyltransferase (CPT II) deficiencyMcArdle: diagnosed with forearm ischemic exercise test — no lactate rise with normal ammonia rise. These patients have lifelong exercise intolerance with recurrent rhabdo episodes

Immobilization deserves special attention: a patient found down for hours — whether from a fall, overdose, or stroke — is at high rhabdomyolysis risk from prolonged muscle compression even without direct trauma. Always check CK in anyone with unknown down time. Consider linking this context to DVT risk from immobilization as a concurrent concern.


Clinical presentation

The classic triad of rhabdomyolysis is muscle pain and weakness, dark tea- or cola-colored urine, and elevated CK. In practice, all three are present together in fewer than 10% of cases. Many patients present with only one or two findings, or with non-specific complaints like fatigue and nausea. High clinical suspicion is essential, particularly after any of the causative events listed above.

Muscle symptoms range widely. Some patients report severe, diffuse myalgia and tenderness. Others have minimal pain despite significant muscle necrosis — this is common in exertional rhabdo after extreme exercise, where patients may feel normal until CK results return. Muscle swelling from fluid sequestration may be visible or palpable. Any tense, woody-feeling compartment warrants immediate compartment pressure measurement.

Urine findings are the most recognizable sign when present. Dark (tea- or cola-colored) urine tests positive for blood on dipstick because myoglobin cross-reacts with the heme peroxidase reagent. The key differentiator from hematuria: urine microscopy shows no red blood cells. The discoloration can range from slightly amber to a deep reddish-brown; the darker the urine, the higher the myoglobin load and the greater the renal risk. Monitoring urine color serially is a direct bedside indicator of treatment response — as fluids work, urine clears.

Systemic signs often include fever (especially in heatstroke or infectious causes), nausea and vomiting, tachycardia, and confusion. These non-specific findings overlap with sepsis, which may also coexist.

Signs of AKI progression: oliguria or anuria, fluid retention and edema, worsening electrolyte imbalances, and rising creatinine. See the AKI nursing reference for full staging criteria and management.


Diagnostics and lab monitoring

Lab testExpected findingClinical significance
CK (creatine kinase)>5× ULN; severe cases 10,000–100,000 U/L or higherPrimary diagnostic marker. Severity correlates with AKI risk. Peak within 24–48 hours, then decline with treatment. No decline = ongoing muscle injury
Urinalysis (dipstick)Blood: positiveMyoglobin cross-reacts with heme peroxidase. Positive blood without RBCs on microscopy = myoglobinuria, not hematuria
Urine microscopyNo RBCs seenDistinguishes myoglobinuria from hematuria — critical differentiating test
Serum creatinine / BUNBoth elevatedIndicates AKI; track trend q4–8h with electrolytes
PotassiumElevated (hyperkalemia)Cell lysis releases intracellular K+. Fatal arrhythmias possible. Most urgent electrolyte problem
PhosphateElevated (hyperphosphatemia)Cell lysis. Binds serum calcium → early hypocalcemia
CalciumLow early (hypocalcemia) → may rise late (hypercalcemia)Early: bound to damaged muscle — do NOT aggressively correct. Late: deposited Ca released from necrotic tissue → rebound hypercalcemia
Uric acidElevated (hyperuricemia)Released from cell nuclei. Contributes to tubular obstruction alongside myoglobin
PT/INR, fibrinogenAbnormal (PT elevated, fibrinogen low)Signs of DIC from thromboplastin release. Order in severe cases
CBCHemoglobin decreasedFluid third-spacing into damaged muscle reduces effective circulating volume and lowers Hgb
Urine myoglobinElevatedDirect confirmation but not always ordered — clinical picture with dipstick + microscopy usually sufficient

Monitoring cadence: Serial CK and BMP (creatinine, BUN, potassium, bicarbonate) every 4–8 hours until CK trend is clearly downward. Hourly urine output via Foley catheter. Continuous cardiac monitoring throughout. Urine color documented with every output check.


Treatment: fluid resuscitation

Aggressive IV fluid resuscitation is the single most important intervention in rhabdomyolysis. The goal is to maintain high urine flow that flushes myoglobin from renal tubules before it precipitates.

Target urine output: 200–300 mL/hr (some guidelines state minimum 1–2 mL/kg/hr). This is substantially higher than standard maintenance targets and requires active monitoring and dose titration.

Fluid choice: Isotonic normal saline (0.9% NaCl) is the first-line agent. Lactated Ringer’s (LR) is contraindicated in patients with hyperkalemia — it contains 4 mEq/L of potassium, which is negligible in normokalemic patients but adds meaningful load when serum K+ is already elevated.

Volume required: Severe rhabdomyolysis often requires 6–12 liters per day in the acute phase. Start with 1–1.5 L/hr bolus in adults with significant CK elevation, then titrate to urine output goal. Reassess frequently — the aggressive volumes needed to protect the kidneys can accumulate quickly in patients with impaired cardiac reserve.

Sodium bicarbonate infusion: Alkalinizing the urine raises tubular pH above 6.5 and reduces myoglobin solubility shift — myoglobin precipitates far less readily in alkaline urine. Typically added as 50–100 mEq sodium bicarbonate to 1 L D5W. This approach is controversial; it is not universally used, and sodium bicarbonate carries its own risks including worsening hypocalcemia (bicarbonate increases calcium-albumin binding) and alkalemia. Use is institution-dependent. Do not use bicarbonate if the patient is already alkalemic or has severe hypocalcemia.

Mannitol: An osmotic diuretic that increases urinary flow and has theoretical free-radical scavenging properties. It is not first-line — only consider after adequate volume loading has been confirmed. Giving mannitol before the patient is volume replete will cause osmotic diuresis that worsens hypovolemia and renal ischemia.

Loop diuretics (furosemide): Generally avoided in rhabdomyolysis. Furosemide acidifies urine, which worsens myoglobin precipitation in tubules. Reserve for management of established fluid overload when volume goals have been met.


Electrolyte management

Electrolyte problemMechanismNursing interventionsMedical treatments
Hyperkalemia (most dangerous)Intracellular K+ released from lysed muscle cells; impaired renal excretion in AKIContinuous cardiac monitoring — peaked T waves, wide QRS, sine wave pattern = emergency. Report any ECG changes immediatelyCalcium gluconate (membrane stabilization — does not lower K+); insulin + dextrose (shifts K+ into cells); sodium bicarbonate; Kayexalate or patiromer (elimination); dialysis for refractory cases
Hypocalcemia (early)Phosphate binds calcium; calcium deposits into necrotic muscle tissueMonitor for Chvostek's and Trousseau's signs; assess for neuromuscular irritability, tetany, seizure risk. Do NOT push calcium unless symptomatic tetany or life-threatening arrhythmiaAsymptomatic hypocalcemia: observe. Symptomatic: IV calcium gluconate. Aggressive correction → rebound hypercalcemia as Ca deposits released from healing muscle
Rebound hypercalcemia (late)Calcium deposited in necrotic muscle released as tissue heals; especially with vitamin D supplementationMonitor calcium serially; late hypercalcemia typically emerges days to weeks after the acute injuryHydration, loop diuretics (once renal function recovering), bisphosphonates in severe cases
HyperphosphatemiaPhosphate released from lysed cellsDietary restriction; monitor for Ca-phosphate product elevation (risk of soft-tissue calcification)Oral phosphate binders (calcium carbonate, sevelamer); dialysis if severe
Metabolic acidosisAKI reduces acid excretion; lactic acid from ischemic muscle; uric acid accumulationMonitor arterial blood gas or venous pH; assess respirations (Kussmaul if severe)Sodium bicarbonate infusion; dialysis if refractory

The calcium picture in rhabdomyolysis confuses many students. Early: calcium drops because phosphate binds it and necrotic muscle sequesters it. The body’s normal reflex would be to replace calcium, but doing so in rhabdomyolysis just loads more calcium into muscle that will later release it all back — worsening hypercalcemia in the recovery phase. The rule: treat hypocalcemia only when it produces symptoms (tetany, seizures, prolonged QT with arrhythmia), not for a low lab number alone. This is one of the more nuanced clinical decisions in rhabdomyolysis management.

For comprehensive coverage of hyperkalemia treatment, see the electrolyte imbalances nursing reference.


Compartment syndrome recognition

Rhabdomyolysis and compartment syndrome exist in a bidirectional relationship: crush injuries cause both simultaneously, and severe rhabdomyolysis itself can worsen compartment pressures through muscle swelling. Every patient with limb trauma or significant muscle injury requires active compartment syndrome surveillance. See the fractures nursing reference for additional orthopedic context.

The 5 P’s of compartment syndrome:

  1. Pain — out of proportion to the injury; worsens with passive stretch of the muscle within the compartment. This is the earliest and most sensitive sign.
  2. Pressure — tense, woody compartment on palpation
  3. Paresthesia — numbness or tingling in the distribution of the nerve running through the compartment
  4. Paralysis — weakness or inability to move the limb; a late sign indicating significant nerve/muscle ischemia
  5. Pulselessness — absent or diminished distal pulse; this is a very late sign. By the time pulses are absent, irreversible damage has often occurred. Never wait for pulselessness before acting.

Compartment pressure threshold: Direct measurement via pressure monitor is the diagnostic standard. Compartment pressure above 30 mmHg, or within 30 mmHg of the patient’s diastolic blood pressure (the delta pressure concept), indicates fasciotomy is required.

Critical nursing rules for suspected compartment syndrome:

  • Never elevate the affected limb above heart level. Elevation reduces arterial perfusion pressure to the compartment, worsening ischemia. Position at heart level.
  • Remove all constrictive bandages, casts, or splints immediately.
  • Do not apply ice — vasoconstriction further reduces perfusion.
  • Report increasing pain, new paresthesia, or pain with passive stretch immediately — do not delay for the full 5 P’s to develop.

AKI and renal replacement therapy

Myoglobin-induced AKI follows the ATN pattern: tubular obstruction and direct toxicity lead to tubular cell death, loss of concentrating ability, and GFR decline. The AKI nursing reference covers KDIGO staging in full. Key rhabdomyolysis-specific points:

AKI trajectory: Creatinine typically rises within 12–24 hours of the muscle injury. In severe cases with very high CK loads, AKI can progress to dialysis-requiring Stage 3 within 48 hours of presentation. Early aggressive fluids are the main tool to prevent this progression.

Indications for dialysis:

  • Fluid overload unresponsive to diuretics (pulmonary edema, respiratory compromise)
  • Severe hyperkalemia unresponsive to medical management (K+ consistently >6.5 mEq/L, or any K+ elevation with ECG changes)
  • Severe metabolic acidosis (pH <7.1) unresponsive to bicarbonate
  • Uremic encephalopathy (altered mental status from uremia)
  • BUN rising above 80–100 mg/dL in symptomatic patients

CRRT vs. intermittent hemodialysis (IHD): Rhabdomyolysis patients are often hemodynamically unstable from fluid third-spacing, volume shifts, and the underlying cause of the muscle injury. Continuous renal replacement therapy (CRRT) is preferred in hemodynamically unstable patients because it removes solutes gradually, avoiding the rapid fluid and electrolyte shifts that IHD produces. IHD can be used once the patient is hemodynamically stable.


Nursing priorities and interventions

  1. Establish IV access immediately. Two large-bore peripheral IVs. Frequent blood draws for serial labs — an arterial line or PICC placed early reduces venipuncture burden and allows continuous blood pressure monitoring.

  2. Insert Foley catheter and monitor urine output hourly. Hourly output is the most direct feedback mechanism for fluid titration. Target: 200–300 mL/hr. Urine below this rate with adequate fluid infusing warrants immediate provider notification.

  3. Begin continuous cardiac monitoring. Hyperkalemia-induced cardiac changes — peaked T waves, PR prolongation, wide QRS, sine wave, ventricular fibrillation — can develop rapidly. Any ECG change requires immediate assessment and provider notification. The cardiac risk runs ahead of the CK level.

  4. Document urine color with every output measurement. Urine color is a real-time indicator of myoglobin concentration. Record as: clear, yellow, amber, tea-colored, or cola/brown. Darkening color = worsening myoglobin burden or insufficient fluid. Clearing color = treatment response.

  5. Track strict intake and output. With 6–12 L/day of IV fluid going in, fluid accumulation is a real risk. Assess lung sounds every shift and with every respiratory complaint. Daily weights. Signs of pulmonary edema — increasing dyspnea, decreased O2 saturation, crackles — require immediate fluid reassessment.

  6. Serial CK and BMP monitoring. CK every 4–8 hours until a clear downward trend is established. BMP (creatinine, BUN, potassium, bicarbonate) on the same cadence. A rising CK after 48 hours indicates ongoing muscle injury — look for an untreated cause (missed compartment syndrome, ongoing drug toxicity, continuing exertion).

  7. Neurovascular checks on affected extremities every 1–2 hours. Assess: sensation, capillary refill, strength, pulse quality, and compartment firmness. Document baseline and report any deterioration promptly.

  8. Pain management. Moderate-to-severe myalgia often requires opioid analgesia. NSAIDs are strictly contraindicated — they are nephrotoxic through prostaglandin inhibition and worsen AKI risk in an already compromised kidney. This is a NCLEX and clinical priority: do not give ibuprofen or ketorolac to a rhabdomyolysis patient.

  9. Renal function monitoring. Creatinine, BUN, and urine output together define AKI stage and trajectory. Declining urine output with rising creatinine despite adequate fluids signals advancing AKI and the need for nephrology involvement.

  10. Identify and treat the underlying cause. Fluids manage the consequences but do not fix the cause. Statins should be held. Toxic ingestions may require specific antidotes. Infectious causes require antibiotics or surgical consultation. Hyperthermia requires active cooling. Seizures require anticonvulsants.


NCLEX tips

  1. Dark tea/cola-colored urine = myoglobinuria. The dipstick tests positive for blood because myoglobin cross-reacts with heme peroxidase — but urine microscopy shows no red blood cells. This dipstick-positive/microscopy-negative pattern is pathognomonic.

  2. CK greater than 5 times the upper limit of normal is the primary diagnostic criterion. Severe cases reach 10,000–100,000 U/L. CK is more sensitive and specific than myoglobin for diagnosis.

  3. Goal urine output in rhabdomyolysis: 200–300 mL/hr. This is far above normal maintenance targets. The high flow rate is necessary to flush myoglobin before it precipitates in renal tubules.

  4. Normal saline is the first-line IV fluid. Avoid lactated Ringer’s when hyperkalemia is present — LR contains potassium (4 mEq/L), which is contraindicated when serum K+ is already elevated.

  5. NSAIDs are contraindicated in rhabdomyolysis. They inhibit prostaglandin-mediated renal vasodilation and worsen AKI. Do not give ibuprofen, naproxen, or ketorolac.

  6. Do not aggressively correct early hypocalcemia. The calcium is bound to damaged muscle tissue. Pushing IV calcium loads more calcium that will later be released from healing tissue, causing rebound hypercalcemia. Treat only symptomatic hypocalcemia (tetany, seizures, arrhythmia).

  7. Hyperkalemia is the most immediately life-threatening electrolyte complication. Monitor continuously for peaked T waves (earliest ECG change), followed by flattened P waves, wide QRS, sine wave pattern, and ventricular fibrillation.

  8. Calcium gluconate stabilizes the cardiac membrane in hyperkalemia. It does not lower the serum potassium level — it only temporarily protects the heart while other treatments (insulin/dextrose, bicarbonate, elimination agents) lower the K+. It buys time.

  9. Statin-induced rhabdomyolysis risk multiplies dramatically with CYP3A4 inhibitors. Simvastatin is the highest-risk statin (metabolized by CYP3A4). CYP3A4 inhibitors include grapefruit juice, azole antifungals (fluconazole, ketoconazole), macrolide antibiotics (clarithromycin, erythromycin), amiodarone, and some calcium channel blockers. Any NCLEX question pairing statins with these agents and muscle symptoms = rhabdomyolysis.

  10. Compartment pressure above 30 mmHg, or within 30 mmHg of diastolic blood pressure, indicates emergent fasciotomy. The delta pressure concept: if diastolic BP is 60 mmHg and compartment pressure is 35 mmHg, the delta = 25 mmHg — fasciotomy threshold met even though compartment pressure is “only” 35.

  11. Never elevate the affected limb above heart level in compartment syndrome. Elevation reduces arterial perfusion pressure to the compartment and worsens ischemia. Position at heart level. This is the opposite of the standard edema-reduction teaching.

  12. Pain out of proportion to the injury is the earliest and most sensitive sign of compartment syndrome — not pulselessness, which is late. Paresthesia (tingling, numbness) indicates nerve ischemia and is also an early warning. Waiting for absent pulses means the window for limb salvage may have passed.

  13. Bicarbonate may be added to IV fluids to alkalinize urine (target pH >6.5) and reduce myoglobin precipitation in tubules. It is not universally used (controversial) and is contraindicated in patients who are already alkalemic or have severe hypocalcemia.

  14. Serial CK monitoring: levels should peak within 24–48 hours and then decline with treatment. CK that fails to decline after 48 hours indicates ongoing muscle injury — look for an untreated source (compartment syndrome, continued toxic exposure, recurrent seizures).

  15. Dialysis indications in rhabdomyolysis: refractory hyperkalemia, severe fluid overload, metabolic acidosis unresponsive to bicarbonate, and uremic encephalopathy. CRRT is preferred over IHD in hemodynamically unstable patients because it avoids rapid fluid and electrolyte shifts.

  16. In heatstroke (temperature >40°C/104°F with CNS dysfunction), aggressive cooling is the primary intervention. Address rhabdomyolysis management after temperature is controlled. Both exertional heatstroke and classic heatstroke can trigger massive rhabdomyolysis.

  17. In electrical injuries, the external burn wound underestimates actual muscle damage. High-voltage current travels through tissue, destroying muscle along its path with minimal surface evidence. Always obtain CK in any electrical injury — the muscle damage visible from outside is the smallest part of the picture.

  18. McArdle disease (glycogen storage disease type V) causes rhabdomyolysis with exercise because the enzyme needed to break down glycogen (myophosphorylase) is absent. These patients have lifelong exercise intolerance with episodic rhabdo. The forearm ischemic exercise test shows no lactate rise (can’t break down glycogen to produce lactate) with a normal ammonia rise.


Summary

Rhabdomyolysis is one of the more demanding conditions in acute care nursing because it threatens two organ systems simultaneously — the kidneys through myoglobin-driven ATN, and the heart through hyperkalemia-driven arrhythmias — while the presenting signs can be subtle or incomplete. The nursing response is anchored in three parallel actions: push isotonic fluids aggressively enough to produce 200–300 mL/hr of urine output, monitor ECG and electrolytes continuously for the hyperkalemia that kills fastest, and surveil affected extremities for compartment syndrome before the 5 P’s are complete.

The subtler clinical knowledge — why early hypocalcemia should not be corrected, why LR is avoided in hyperkalemia, why CYP3A4 inhibitors turn statins dangerous, why elevating the limb worsens compartment ischemia — is what separates a nurse who manages the protocol from one who understands why the protocol exists.

For related content: AKI nursing for renal staging and management, electrolyte imbalances reference for hyperkalemia and hypocalcemia management, sepsis nursing for infectious triggers, fractures nursing for crush injury and compartment syndrome context, DVT nursing for immobilization risks, heart failure nursing for fluid overload management context, and sickle cell disease nursing for hemolysis and renal complications.